Combined plasma levels of A-type-natriuretic peptide and adrenomedullin are associated with appropriate anti-arrhythmia therapy in patients with an implantable cardioverter defibrillator but no prior device therapy
The combination of ANP and ADM are independently associated with the risk of ICD-therapy in patients with an ICD that has never served, and may participate in stratifying patients who may benefit most from ICD generator replacement.
Authors
- Paul Guedeney (ORCID: https://orcid.org/0000-0002-2012-4137)
- Farzin Beygui (ORCID: https://orcid.org/0000-0003-2170-8983)
- Vincent Roule (ORCID: https://orcid.org/0000-0002-1291-4024)
- Paul Milliez (ORCID: https://orcid.org/0000-0003-4820-5585)
- Johanne Silvain (ORCID: https://orcid.org/0000-0002-1901-2808)
- Laure Champ‐Rigot (ORCID: https://orcid.org/0000-0001-5769-4398)
- Michel Zeitouni (ORCID: https://orcid.org/0000-0001-9562-3128)
- Katrien Blanchart (ORCID: https://orcid.org/0000-0002-5849-0917)
- Nicolas Vignolles
- Gilles Montalescot
- Pierre Ollitraut
- Estelle Gandjbakhch
Institutions
- Inserm (FR)
- Sorbonne Université (FR)
- Normandie Université (FR)
- Pitié-Salpêtrière Hospital (FR)
- Université Paris 1 Panthéon-Sorbonne (FR)
- Université de Caen Normandie (FR)
Publication Details
- Journal
- Biomarkers
- Published
- 2025-07-04
- DOI
- https://doi.org/10.1080/1354750x.2025.2553630
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00